WRBY
Warby Parker Inc.
Medical Instruments & Supplies · Healthcare · United States
24.59
close · 2026-10-29
value
12
cheaper than peers12
quality
23
stronger fundamentals23
ranked against
Medical Instruments & Supplies
value
quality
33 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 3.58× | 34 |
| forward P/E | 40.00× | 30 |
| price to book | 7.74× | 17 |
| EV to EBITDA | 60.62× | 13 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 9.8% | 58 |
| return on equity | 2.1% | 45 |
| operating margin | 1.4% | 26 |
| debt to equity | 64.0% | 25 |
4 of 4 measures available
Facts
| market cap | $3B |
| free cash flow | $16.9M |
| employees | 2,275 |
| first trade | 2021-09-29 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.01 | -0.17 | -0.54 | -0.96 |
| free cash flow | $43.7M | $34.7M | $7.3M | -$49.8M |
| net income | $1.6M | -$20.4M | -$63.2M | -$110.4M |
| revenue | $871.9M | $771.3M | $669.8M | $598.1M |